Cargando…
SLC1A4: A Powerful Prognostic Marker and Promising Therapeutic Target for HCC
SLC1A4, a Na-dependent neutral amino acid transporter, was considered to participate in the various pathobiological process, including tumorigenesis. However, the correlation between SLC1A4 and Hepatocellular Carcinoma (HCC) remains unclear. In our study, integrative bioinformatics and functional pr...
Autores principales: | Peng, Xiaozhen, Chen, Ruochan, Cai, Shenglan, Lu, Shanshan, Zhang, Yiya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991385/ https://www.ncbi.nlm.nih.gov/pubmed/33777811 http://dx.doi.org/10.3389/fonc.2021.650355 |
Ejemplares similares
-
Integrative Transcriptomic, Proteomic and Functional Analysis Reveals ATP1B3 as a Diagnostic and Potential Therapeutic Target in Hepatocellular Carcinoma
por: Lu, Shanshan, et al.
Publicado: (2021) -
Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma
por: Cai, Shenglan, et al.
Publicado: (2021) -
Cuproptosis-related prognostic signatures predict the prognosis and immunotherapy in HCC patients
por: Peng, Hong, et al.
Publicado: (2023) -
Gene Signatures and Prognostic Values of m(6)A Genes in Nasopharyngeal Carcinoma
por: Lu, Shanshan, et al.
Publicado: (2020) -
EPDR1 correlates with immune cell infiltration in hepatocellular carcinoma and can be used as a prognostic biomarker
por: Chen, Ruochan, et al.
Publicado: (2020)